Bibliographic Details
| Title: |
Interest in and Preference for Long-acting Injectable Antiretroviral Therapy in the Era of Approved Cabotegravir/Rilpivirine Among Reproductive-aged Women in the US South. |
| Authors: |
Collins, Lauren F, Sheth, Anandi N, Tisdale, Tina, Mehta, C Christina, Daniel, Gaea, Westreich, Daniel, Kassaye, Seble, Topper, Elizabeth F, Konkle-Parker, Deborah, Rana, Aadia, Alcaide, Maria L, Philbin, Morgan M |
| Source: |
Clinical Infectious Diseases; Jan2025, Vol. 80 Issue 1, p164-167, 4p |
| Subject Terms: |
RILPIVIRINE, HEALTH services accessibility, REPRODUCTIVE health, THERAPEUTICS, ANTIRETROVIRAL agents, PATIENT safety, HIV infections, DECISION making, HIGHLY active antiretroviral therapy, INJECTIONS, ATTITUDE (Psychology), DRUG approval, DRUG efficacy, WOMEN'S health, PATIENTS' attitudes |
| Geographic Terms: |
UNITED States |
| Abstract: |
Among 103 reproductive-aged women with human immunodeficiency virus (HIV) in the US South surveyed post-approval of long-acting injectable (LAI) cabotegravir/rilpivirine, nearly two-thirds reported willingness to try LAI antiretroviral therapy (ART). Most expressed preference for LAI over daily oral ART and had minimal concerns over potential LAI-ART use impacting reproductive health. [ABSTRACT FROM AUTHOR] |
|
Copyright of Clinical Infectious Diseases is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Complementary Index |
